Tenax Therapeutics (TENX) Times Interest Earned (2010 - 2024)
Tenax Therapeutics recorded quarterly Times Interest Earned of $7295.0 in Q4 2024, up 1205.54% quarter-over-quarter from -$659.86 in Q3 2024, and up 221.54% year-over-year from $2268.8 in Q1 2024.
Tenax Therapeutics' Times Interest Earned history runs 10 years deep, the most recent figure standing at $7295.0 for Q4 2024.
- In Q4 2024, Times Interest Earned rose 221.54% year-over-year to $7295.0; the TTM figure through Sep 2025 stood at $47231.0 (up 4983.67% YoY), while the FY2024 annual figure was -$847.57, down 147.04% from the prior year.
- Times Interest Earned came in at $7295.0 for Q4 2024 at Tenax Therapeutics, up from -$659.86 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $7842.7 in Q3 2022 to a low of -$38743.3 in Q1 2021.
- A 5-year average of -$1867.0 and a median of -$37.0 in 2023 frame the typical range for Times Interest Earned.
- On a YoY basis, Times Interest Earned climbed as much as 221.54% in 2024 and fell as far as 401.13% in 2024.
- Tenax Therapeutics' Times Interest Earned stood at $1072.0 in 2020, then soared by 445.41% to $5846.7 in 2021, then jumped by 34.14% to $7842.7 in 2022, then plunged by 176.53% to -$6002.3 in 2023, then surged by 221.54% to $7295.0 in 2024.
- According to Business Quant data, Times Interest Earned over the past three periods registered $7295.0, -$659.86, and -$407.89 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7,295.00 |
| Sep 30, 2024 | -659.86 |
| Jun 30, 2024 | -407.89 |
| Mar 31, 2024 | -488.63 |
| Dec 31, 2023 | -6,002.29 |
| Sep 30, 2023 | 396.74 |
| Jun 30, 2023 | 135.45 |
| Mar 31, 2023 | -209.45 |
| Sep 30, 2022 | 7,842.71 |
| Jun 30, 2022 | 1,928.50 |
| Mar 31, 2022 | 1,050.88 |
| Jun 30, 2021 | 5,846.73 |
| Mar 31, 2021 | -38,743.33 |
| Dec 31, 2020 | 1,071.99 |
| Sep 30, 2020 | -3,647.74 |
| Jun 30, 2020 | -5,280.89 |
| Dec 31, 2015 | -6,918.05 |
| Sep 30, 2015 | -5,435.32 |
| Jun 30, 2015 | -3,473.93 |
| Apr 30, 2013 | -1.99 |
| Jan 31, 2013 | -1.94 |
| Oct 31, 2012 | -0.79 |
| Jul 31, 2012 | -0.87 |
| Apr 30, 2012 | -2.44 |
| Jan 31, 2012 | -0.35 |
| Oct 31, 2011 | -2.36 |
| Jul 31, 2011 | -5.57 |
| Apr 30, 2011 | -22.38 |
| Jan 31, 2011 | -63.93 |
| Oct 31, 2010 | 382.08 |
| Jul 31, 2010 | 2,506.80 |